Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesGenetic disorders, not elsewhere classifiedICD-10-CM qa0-neurodevelopmental-disorders-genetic-variants
    Ask Trek AI about this page

    ICD-10-CM Code For Neurodevelopmental Disorders Related To Specific Genetic Pathogenic Variants: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group QA0 includes neurodevelopmental disorders attributed to specific pathogenic genetic variants, covering conditions that impair cognitive, behavioral, communication, motor, and social development. These ICD-10-CM diagnosis codes are used to document clinical presentations, genetic etiology, severity of developmental impairment, and associated neurologic or systemic involvement. Accurate coding within the ICD-10-CM QA0 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Neurodevelopmental Disorders Related To Specific Genetic Pathogenic Variants: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM QA0: Neurodevelopmental Disorders Related To Specific Genetic Pathogenic Variants Overview

    This group represents neurodevelopmental disorders caused by specific pathogenic genetic variants that primarily affect brain development, cognition, behavior, and neurodevelopmental function. These diagnoses target the nervous system and developmental domains across the lifespan. Accurate coding matters for appropriate claim processing and documentation of the genetic etiology influencing clinical management and resource use.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use codes from this group when a neurodevelopmental disorder has been attributed to a confirmed pathogenic genetic variant or when documentation explicitly links developmental impairments to a specific genetic etiology. These codes are appropriate for encounters where the genetic cause is relevant to clinical management, prognosis, or billing and where documentation supports the association.

    ICD-10-CM Codes

    13 rows

    ICD-10-CM CodeDescription
    QA0.0101SCN2A-related neurodevelopmental disorder
    QA0.0102CACNA1A-related neurodevelopmental disorder
    QA0.0109Neurodevelopmental disorder related to pathogenic variant in other ion channel gene
    QA0.011Neurodevelopmental disorders, related to pathogenic variants in glutamate receptor genes
    QA0.012Neurodevelopmental disorders, related to pathogenic variants in other receptor genes
    QA0.0131SLC6A1-related disorder
    QA0.0139Neurodevelopmental disorder, related to pathogenic variant in other transporter or solute carrier gene
    QA0.0141Syntaxin-binding protein 1-related disorder
    QA0.0142DLG4-related synaptopathy
    QA0.0149Neurodevelopmental disorder, related to pathogenic variant in other synapse related gene
    QA0.0151FOXG1 syndrome
    QA0.0159Neurodevelopmental disorder, related to other genes associated with transcription and gene expression
    QA0.8Other neurodevelopmental disorders related to pathogenic variants in other specific genes

    DRG Codes

    3 rows

    DRG CodeDescription
    564Other Musculoskeletal System and Connective Tissue Diagnoses with MCC
    565Other Musculoskeletal System and Connective Tissue Diagnoses with CC
    566Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC

    Typical Clinical Scenarios

    • A 6-month-old infant is brought to pediatric neurology by parents for delayed developmental milestones including poor head control, absent social smiling, and failure to meet motor milestones. Genetic testing reveals a pathogenic single-gene variant known to cause a neurodevelopmental disorder with early-onset global developmental delay; the visit documents the genetic etiology as the primary diagnosis guiding prognosis and family counseling. Typical codes: QA0.0101, QA0.0109
    • A school-age child with known intellectual disability and refractory epilepsy presents for a routine multidisciplinary clinic visit to assess ongoing cognitive decline and optimize supportive therapies. The child’s established genetic pathogenic variant is recorded as the underlying cause of the neurodevelopmental disorder and coexisting neurologic complications are managed as sequelae of that genetic diagnosis. Typical codes: QA0.011, QA0.0139
    • An adult with a previously undiagnosed neurodevelopmental disorder is hospitalized after an acute behavioral crisis and aggression; inpatient evaluation, including chromosomal microarray and targeted sequencing, identifies a pathogenic variant explaining lifelong cognitive impairment and recent psychiatric manifestations. The genetic diagnosis is assigned to explain the chronic neurodevelopmental condition and to inform discharge planning and referral to specialized services. Typical codes: QA0.0142, QA0.8

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.